NASDAQ : RARE
Ultragenyx Pharmaceutical Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 16.78 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 1.65B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Ultragenyx Pharmaceutical Inc. (RARE) reported revenue of 717.00M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 717.00M | 673.00M | 560.00M | 434.00M | 363.33M | 351.41M |
| Cost of Revenue | 866.00M | 859.00M | 775.00M | 693.00M | 734.11M | 513.16M |
| Gross Profit | -149.00M | -186.00M | -215.00M | -259.00M | -370.78M | -161.75M |
| Selling, General & Admin | 349.00M | 349.00M | 321.00M | 310.00M | 278.14M | 219.98M |
| Operating Expenses | 349.00M | 349.00M | 321.00M | 310.00M | 278.14M | 219.98M |
| Operating Income | -498.00M | -535.00M | -536.00M | -569.00M | -648.92M | -381.74M |
| Interest Expense | -77.00M | -62.00M | -63.00M | -66.00M | -43.02M | -29.42M |
| Interest & Investment Income | 23.00M | 25.00M | 37.00M | 27.00M | 11.07M | 1.93M |
| Other Non Operating Income (Expenses) | 1.00M | -5.00M | -1.00M | -1.57M | -1.69M | |
| EBT Excluding Unusual Items | -552.00M | -571.00M | -567.00M | -609.00M | -682.43M | -410.92M |
| Merger & Restructuring Charges | -30.00M | |||||
| Gain (Loss) on Sale of Investments | -19.30M | -42.06M | ||||
| Pretax Income | -582.00M | -571.00M | -567.00M | -609.00M | -701.73M | -452.98M |
| Income Tax Expense | 4.00M | 4.00M | 2.00M | -2.00M | 5.70M | 1.04M |
| Net Income | -586.00M | -575.00M | -569.00M | -607.00M | -707.42M | -454.02M |
| Net Income to Common | -586.00M | -575.00M | -569.00M | -607.00M | -707.42M | -454.02M |
| Shares Outstanding (Basic) | 100.55M | 98.60M | 90.50M | 73.50M | 69.91M | 67.80M |
| Shares Outstanding (Diluted) | 100.55M | 98.60M | 90.50M | 73.50M | 69.91M | 67.80M |
| EPS (Basic) | -5.83 | -5.83 | -6.29 | -8.26 | -10.12 | -6.70 |
| EPS (Diluted) | -5.83 | -5.83 | -6.29 | -8.26 | -10.12 | -6.70 |
| Free Cash Flow | -489.00M | -472.00M | -421.00M | -519.00M | -496.59M | -411.79M |
| Free Cash Flow Per Share | -4.86 | -4.79 | -4.65 | -7.06 | -7.10 | -6.07 |
| Gross Margin | -20.78% | -27.64% | -38.39% | -59.68% | -102.05% | -46.03% |
| Operating Margin | -69.46% | -79.50% | -95.71% | -131.11% | -178.60% | -108.63% |
| Profit Margin | -81.73% | -85.44% | -101.61% | -139.86% | -194.70% | -129.20% |
| Free Cash Flow Margin | -68.20% | -70.13% | -75.18% | -119.59% | -136.68% | -117.18% |
| EBITDA | -465.00M | -500.00M | -500.00M | -543.00M | -630.70M | -368.50M |
| EBITDA Margin | -64.85% | -74.29% | -89.29% | -125.11% | -173.59% | -104.86% |
| D&A For EBITDA | 33.00M | 35.00M | 36.00M | 26.00M | 18.22M | 13.24M |
| EBIT | -498.00M | -535.00M | -536.00M | -569.00M | -648.92M | -381.74M |
| EBIT Margin | -69.46% | -79.50% | -95.71% | -131.11% | -178.60% | -108.63% |
| Revenue as Reported | 717.00M | 673.00M | 560.00M | 434.00M | 363.33M | 351.41M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 125.00M | 421.00M | 174.00M | 213.58M | 132.94M | 307.58M |
| Short-Term Investments | 167.00M | 259.00M | 436.00M | 363.62M | 614.82M | 432.61M |
| Cash & Short-Term Investments | 292.00M | 680.00M | 610.00M | 577.21M | 747.76M | 740.20M |
| Accounts Receivable | 200.00M | 158.00M | 122.00M | 73.39M | 40.45M | 28.43M |
| Other Receivables | 2.00M | 2.00M | 3.00M | 1.10M | 6.40M | 16.00M |
| Receivables | 202.00M | 160.00M | 125.00M | 74.49M | 46.84M | 44.43M |
| Inventory | 59.00M | 52.00M | 45.00M | 33.97M | 26.77M | 16.23M |
| Prepaid Expenses | 44.00M | 46.00M | 30.00M | 44.51M | 55.74M | |
| Restricted Cash | 9.00M | 13.00M | 7.00M | 2.01M | 862.00K | |
| Other Current Assets | 61.66M | |||||
| Total Current Assets | 606.00M | 951.00M | 817.00M | 732.18M | 883.90M | 856.60M |
| Property, Plant & Equipment | 235.00M | 267.00M | 292.00M | 314.47M | 285.73M | 176.18M |
| Long-Term Investments | 144.00M | 57.00M | 135.00M | 199.90M | 148.97M | 293.86M |
| Goodwill | 44.00M | 44.00M | 44.00M | 44.41M | 44.41M | 44.41M |
| Other Intangible Assets | 172.00M | 176.00M | 178.00M | 166.27M | 160.10M | 130.79M |
| Other Long-Term Assets | 63.00M | 37.00M | 37.00M | 33.78M | 22.34M | 20.56M |
| Total Assets | 1.26B | 1.53B | 1.50B | 1.49B | 1.55B | 1.52B |
| Accounts Payable | 39.00M | 31.00M | 39.00M | 42.11M | 43.27M | 17.14M |
| Accrued Expenses | 221.00M | 265.00M | 241.00M | 196.49M | 204.68M | 145.56M |
| Current Portion of Long-Term Debt | 76.00M | 69.00M | 50.00M | 29.24M | ||
| Current Portion of Leases | 12.00M | 10.00M | 12.60M | 11.78M | 11.07M | |
| Current Unearned Revenue | 1.48M | 7.61M | ||||
| Other Current Liabilities | 15.00M | 7.00M | 4.00M | |||
| Total Current Liabilities | 351.00M | 384.00M | 344.00M | 280.44M | 261.21M | 181.37M |
| Long-Term Debt | 1.13B | 1.15B | 820.00M | 862.33M | 875.44M | 351.79M |
| Long-Term Leases | 24.00M | 30.00M | 30.57M | 19.81M | 30.90M | |
| Long-Term Unearned Revenue | 1.47M | |||||
| Long-Term Deferred Tax Liabilities | 30.00M | 30.00M | 30.00M | 30.06M | 31.67M | 33.31M |
| Other Long-Term Liabilities | 41.00M | 20.00M | 17.00M | 12.21M | 4.82M | 1.00M |
| Total Liabilities | 1.55B | 1.60B | 1.24B | 1.22B | 1.19B | 599.84M |
| Common Stock | 82.00K | 70.00K | 69.00K | |||
| Additional Paid-In Capital | 4.52B | 4.45B | 4.21B | 3.66B | 3.14B | 3.00B |
| Retained Earnings | -4.81B | -4.53B | -3.96B | -3.39B | -2.78B | -2.07B |
| Treasury Stock | -10.00M | -8.00M | -4.00M | -432.00K | ||
| Comprehensive Income & Other | 10.00M | 9.00M | 3.00M | 1.08M | -6.57M | -1.40M |
| Total Common Equity | -291.00M | -80.00M | 255.00M | 275.41M | 352.49M | 922.56M |
| Minority Interest | 7.00M | 7.00M | 7.00M | |||
| Shareholders' Equity | -284.00M | -73.00M | 262.00M | 275.41M | 352.49M | 922.56M |
| Total Liabilities & Equity | 1.26B | 1.53B | 1.50B | 1.49B | 1.55B | 1.52B |
| Total Debt | 1.20B | 1.25B | 910.00M | 934.74M | 907.03M | 393.76M |
| Net Cash (Debt) | -766.00M | -515.00M | -165.00M | -157.63M | -10.30M | 605.37M |
| Net Cash Per Share | -7.62 | -5.22 | -1.82 | -2.14 | -0.15 | 8.93 |
| Filing Date Shares Outstanding | 98.29M | 96.43M | 92.50M | 82.34M | 70.22M | 69.38M |
| Total Common Shares Outstanding | 98.30M | 96.40M | 92.48M | 82.32M | 70.20M | 69.34M |
| Working Capital | 255.00M | 567.00M | 473.00M | 451.75M | 622.69M | 675.24M |
| Book Value Per Share | -2.96 | -0.83 | 2.76 | 3.35 | 5.02 | 13.30 |
| Tangible Book Value | -507.00M | -300.00M | 33.00M | 64.74M | 147.98M | 747.37M |
| Tangible Book Value Per Share | -5.16 | -3.11 | 0.36 | 0.79 | 2.11 | 10.78 |
| Land | 17.00M | 17.00M | 16.62M | 16.62M | 15.49M | |
| Buildings | 182.00M | 182.00M | 181.36M | 2.80M | ||
| Machinery | 125.00M | 119.00M | 116.26M | 70.28M | 54.31M | |
| Construction In Progress | 189.45M | 76.85M | ||||
| Leasehold Improvements | 55.00M | 58.00M | 58.68M | 43.94M | 44.08M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -586.00M | -575.00M | -569.00M | -607.00M | -707.42M | -454.02M |
| Depreciation & Amortization | 33.00M | 35.00M | 36.00M | 26.00M | 18.22M | 13.24M |
| Asset Writedown & Restructuring Costs | 75.03M | |||||
| Loss (Gain) From Sale of Investments | -2.00M | -4.00M | -13.00M | -13.00M | 22.00M | 48.67M |
| Stock-Based Compensation | 139.00M | 153.00M | 158.00M | 135.00M | 130.38M | 104.95M |
| Other Operating Activities | -45.00M | -52.00M | -40.00M | 21.09M | 11.71M | |
| Change in Accounts Receivable | -71.00M | -31.00M | -34.00M | -23.00M | -12.07M | -5.43M |
| Change in Inventory | -12.00M | -6.00M | -11.00M | -7.00M | -9.70M | -3.12M |
| Change in Accounts Payable | 49.00M | 24.00M | 47.00M | -1.00M | 79.84M | 32.31M |
| Change in Unearned Revenue | -57.49M | |||||
| Change in Other Net Operating Assets | 10.00M | -10.00M | 12.00M | 15.00M | 3.80M | -29.51M |
| Operating Cash Flow | -485.00M | -466.00M | -414.00M | -475.00M | -380.46M | -338.69M |
| Capital Expenditures | -4.00M | -6.00M | -7.00M | -44.00M | -116.12M | -73.09M |
| Cash Acquisitions | -75.03M | |||||
| Sale (Purchase) of Intangibles | -5.00M | -15.00M | -13.00M | -3.00M | -30.00M | |
| Investment in Securities | 53.00M | 258.00M | 4.00M | 221.00M | -69.66M | -121.34M |
| Other Investing Activities | -4.00M | -1.00M | -2.00M | -6.00M | -844.00K | -942.00K |
| Investing Cash Flow | 40.00M | 236.00M | -18.00M | 168.00M | -291.65M | -195.37M |
| Issuance of Common Stock | 5.00M | 86.00M | 392.00M | 387.00M | 10.81M | 119.04M |
| Other Financing Activities | 392.00M | 392.00M | 7.00M | 1.00M | 490.39M | -492.00K |
| Financing Cash Flow | 397.00M | 478.00M | 399.00M | 388.00M | 501.21M | 118.55M |
| Foreign Exchange Rate Adjustments | -1.00M | 4.00M | -2.00M | -1.07M | -1.19M | |
| Net Cash Flow | -49.00M | 252.00M | -35.00M | 81.00M | -171.98M | -416.71M |
| Free Cash Flow | -489.00M | -472.00M | -421.00M | -519.00M | -496.59M | -411.79M |
| Free Cash Flow Margin | -68.20% | -70.13% | -75.18% | -119.59% | -136.68% | -117.18% |
| Free Cash Flow Per Share | -4.86 | -4.79 | -4.65 | -7.06 | -7.10 | -6.07 |
| Levered Free Cash Flow | -221.79M | -251.12M | -207.00M | -312.54M | -370.58M | -244.82M |
| Unlevered Free Cash Flow | -173.66M | -212.38M | -167.62M | -271.29M | -343.70M | -226.43M |
| Cash Income Tax Paid | 4.00M | 4.00M | ||||
| Change in Working Capital | -24.00M | -23.00M | 14.00M | -16.00M | 60.23M | -63.24M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.58B | 2.22B | 3.88B | 3.93B | 3.25B | 5.73B |
| Enterprise Value | 2.35B | 2.64B | 3.99B | 4.35B | 3.15B | 5.18B |
| Last Close Price | 16.10 | 23.00 | 42.07 | 47.82 | 46.33 | 84.09 |
| PS Ratio | 2.21 | 3.29 | 6.93 | 9.05 | 8.94 | 16.31 |
| PB Ratio | -30.34 | 14.82 | 14.26 | 9.21 | 6.21 | |
| P/TBV Ratio | 117.64 | 60.65 | 21.95 | 7.67 | ||
| EV/Sales Ratio | 3.28 | 3.92 | 7.13 | 10.03 | 8.67 | 14.75 |
| Debt / Equity Ratio | -4.23 | -17.15 | 3.47 | 3.39 | 2.57 | 0.43 |
| Net Debt / Equity Ratio | -2.70 | -7.05 | 0.63 | 0.57 | 0.03 | -0.66 |
| Net Debt / EBITDA Ratio | -1.65 | -1.03 | -0.33 | -0.29 | -0.02 | 1.64 |
| Net Debt / FCF Ratio | -1.57 | -1.09 | -0.39 | -0.30 | -0.02 | 1.47 |
| Asset Turnover | 0.56 | 0.44 | 0.37 | 0.29 | 0.24 | 0.21 |
| Inventory Turnover | 16.42 | 17.71 | 19.63 | 22.82 | 34.15 | 35.05 |
| Quick Ratio | 1.41 | 2.19 | 2.14 | 2.32 | 3.04 | 4.33 |
| Current Ratio | 1.73 | 2.48 | 2.38 | 2.61 | 3.38 | 4.72 |
| Return on Equity (ROE) | -608.47% | -211.75% | -193.34% | -110.96% | -43.72% | |
| Return on Assets (ROA) | -24.22% | -22.03% | -22.38% | -23.42% | -26.44% | -14.54% |
| Return on Capital Employed (ROCE) | -54.50% | -46.60% | -46.20% | -47.00% | -50.50% | -28.50% |
| Earnings Yield | -36.20% | -25.96% | -14.66% | -15.46% | -21.78% | -7.92% |
| FCF Yield | -30.90% | -21.31% | -10.85% | -13.22% | -15.29% | -7.18% |
| Buyback Yield / Dilution | -4.21% | -8.95% | -23.13% | -5.13% | -3.12% | -11.42% |